May Lwin

2.7k total citations
6 papers, 23 citations indexed

About

May Lwin is a scholar working on Rheumatology, Infectious Diseases and Neurology. According to data from OpenAlex, May Lwin has authored 6 papers receiving a total of 23 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 3 papers in Infectious Diseases and 2 papers in Neurology. Recurrent topics in May Lwin's work include Rheumatoid Arthritis Research and Therapies (3 papers), COVID-19 Clinical Research Studies (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). May Lwin is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), COVID-19 Clinical Research Studies (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). May Lwin collaborates with scholars based in United Kingdom, Switzerland and Netherlands. May Lwin's co-authors include Christopher Holroyd, Christopher J Edwards, Alice Mason, Saul N. Faust, Rob J. van der Geest, Sven Plein, Simon Fraser, Arka Das, Hans de Graaf and Lyndsey Goulston and has published in prestigious journals such as Lara D. Veeken, Lupus and Journal of Cardiovascular Magnetic Resonance.

In The Last Decade

May Lwin

5 papers receiving 23 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May Lwin United Kingdom 2 15 14 8 4 3 6 23
Bryce W. Q. Tan Singapore 1 26 1.7× 12 0.9× 10 1.3× 2 0.5× 7 2.3× 2 41
Charlotte Bourgoin France 2 14 0.9× 9 0.6× 13 1.6× 1 0.3× 5 23
Raffaella Landi Italy 4 21 1.4× 4 0.3× 9 1.1× 10 2.5× 1 0.3× 4 33
Mikhail Gilyarov Russia 2 20 1.3× 3 0.2× 16 2.0× 7 1.8× 3 1.0× 2 37
Ben Butler-Cole United Kingdom 3 6 0.4× 8 0.6× 9 1.1× 1 0.3× 3 1.0× 5 35
Richard C. Kho Philippines 2 6 0.4× 19 1.4× 6 0.8× 5 39
Tímea Baló Hungary 3 5 0.3× 5 0.4× 5 0.6× 2 0.5× 1 0.3× 3 19
Shaghayegh Shahmirzaei Iran 3 16 1.1× 3 0.2× 23 2.9× 2 0.5× 2 0.7× 7 36
Chiara E. Geyer Netherlands 4 6 0.4× 4 0.3× 4 0.5× 10 2.5× 4 29
Jeffrey M. Zink United States 3 3 0.2× 12 0.9× 4 0.5× 4 1.0× 1 0.3× 4 24

Countries citing papers authored by May Lwin

Since Specialization
Citations

This map shows the geographic impact of May Lwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Lwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Lwin more than expected).

Fields of papers citing papers by May Lwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May Lwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Lwin. The network helps show where May Lwin may publish in the future.

Co-authorship network of co-authors of May Lwin

This figure shows the co-authorship network connecting the top 25 collaborators of May Lwin. A scholar is included among the top collaborators of May Lwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May Lwin. May Lwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
2.
Fraser, Simon, et al.. (2023). P117 Machine-learning derived characteristics associated with tapering TNF inhibitors in individuals with rheumatoid arthritis. Lara D. Veeken. 62(Supplement_2). 1 indexed citations
3.
Mason, Alice, et al.. (2023). CAR T Cell Therapy: A New Hope for Refractory Lupus?. 2(2). 1–1. 1 indexed citations
4.
Mason, Alice, et al.. (2021). Lupus, vaccinations and COVID-19: What we know now. Lupus. 30(10). 1541–1552. 19 indexed citations
5.
Lwin, May, Christopher Holroyd, Dinny Wallis, et al.. (2020). Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?. Rheumatology Advances in Practice. 4(2). rkaa061–rkaa061. 1 indexed citations
6.
Lwin, May, et al.. (2020). Does COVID-19 cause an increased risk of hospitalisation or death in patients with inflammatory rheumatic diseases treated with bDMARDs or tsDMARDs?. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026